Clinical trial
Study of the Combination of Anecortave Acetate and Triamcinolone Acetonide for…
NCT00211419 · Manhattan Eye, Ear & Throat Hospital, Other · Completed
Key facts
| NCT number | NCT00211419 |
|---|---|
| Title | Study of the Combination of Anecortave Acetate and Triamcinolone Acetonide for the Treatment of Exudative Age-Related Macular Degeneration (AMD) |
| Official title | Pilot Study of the Combination of Anecortave Acetate 15mg Delivered by Posterior Juxtascleral Injection and Triamcinolone Acetonide 4mg Delivered by Intravitreal Injection for the Treatment of Exudative Age-Related Macular Degeneration (AMD) |
| Lead sponsor | Manhattan Eye, Ear & Throat Hospital, Other |
| Collaborators | Alcon Research Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Maculopathy, Age-Related |
| Intervention type | Drug, Procedure |
| Interventions | Anecortave Acetate 15 mg, Triamcinolone Acetate 4 mg, Photodynamic Therapy with Verteporfin, Thermal Laser |
| First posted | Sep 21, 2005 |
| Last update posted | Oct 24, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: